Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Corvus Pharmaceuticals Inc shares valued at $1,000,000 were purchased by MILLER RICHARD A MD on May 06 ’24. At $1.73 per share, MILLER RICHARD A MD acquired 577,634 shares. The insider’s holdings grew to 577,634 shares worth approximately $1.9 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Jones William Benton purchased 20,000 shares, netting a total of over 34,624 in proceeds. Following the buying of shares at $1.73 each, the insider now holds 153,773 shares.
As published in their initiating research note from Oppenheimer on August 18, 2023, Corvus Pharmaceuticals Inc [CRVS] has been an Outperform and the price target has been revised to $7. As of May 27, 2021, Cantor Fitzgerald has initiated its “an Overweight” rating for CRVS. Earlier on February 10, 2021, Mizuho downgraded its rating. Their new recommendation was “a Neutral” for CRVS stock which previously was a “a Buy”.
Analyzing CRVS Stock Performance
During the last five days, there has been a surge of approximately 28.02%. Over the course of the year, Corvus Pharmaceuticals Inc shares have jumped approximately 86.93%. Shares of the company reached a 52-week high of $3.58 on 08/07/24 and a 52-week low of $1.30 on 04/18/24. A 50-day SMA is recorded $2.17, while a 200-day SMA reached $1.90. Nevertheless, trading volume fell to 0.79 million shares from 0.36 million shares the previous day.
Support And Resistance Levels for Corvus Pharmaceuticals Inc (CRVS)
According to the 24-hour chart, there is a support level at 3.13, which, if violated, would cause prices to drop to 2.98. In the upper region, resistance lies at 3.51. The next price resistance is at 3.74. RSI (Relative Strength Index) is 72.81 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.41, which suggests the price will decrease in the coming days. Percent R is at 19.59%, indicating bullish price movement. Stochastics%K at holding indicates that the stock is to be held.
